Influence of Polymer Concentration on Drying of SPION Dispersions by Electrospinning.

drying electrospinning nanofibers poloxamer 188 polyethylene oxide superparamagnetic iron oxide nanoparticles

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
30 May 2023
Historique:
received: 27 03 2023
revised: 16 05 2023
accepted: 26 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

To improve the physical stability of nanoparticle dispersions, several methods for their transformation into stable and easily dispersible dry products have been investigated thus far. Recently, electrospinning was shown to be a novel nanoparticle dispersion drying method, which addresses the crucial challenges of the current drying methods. It is a relatively simple method, but it is affected by various ambient, process, and dispersion parameters, which impact the properties of the electrospun product. The aim of this study was, thus, to investigate the influence of the most important dispersion parameter, namely the total polymer concentration, on the drying method efficiency and the properties of the electrospun product. The formulation was based on a mixture of hydrophilic polymers poloxamer 188 and polyethylene oxide in the weight ratio of 1:1, which is acceptable for potential parenteral application. We showed that the total polymer concentration of prior-drying samples is closely related to their viscosity and conductivity, also affecting the morphology of the electrospun product. However, the change in morphology of the electrospun product does not affect the efficiency of SPION reconstitution from the electrospun product. Regardless of the morphology, the electrospun product is not in powder form and is therefore safer to handle compared to powder nanoformulations. The optimal total polymer concentration in the prior-drying SPION dispersion, which enables the formation of an easily dispersible electrospun product with high SPION-loading (65% (

Identifiants

pubmed: 37376067
pii: pharmaceutics15061619
doi: 10.3390/pharmaceutics15061619
pmc: PMC10302812
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Slovenian Research Agency
ID : P1-0189, P1-0420, P2-0089, J1-7302, J2-3043, J3-3079

Références

Mol Pharm. 2013 Dec 2;10(12):4509-26
pubmed: 24191694
Int J Pharm. 2021 Dec 15;610:121160
pubmed: 34624446
Int J Pharm. 2019 Jun 10;564:293-298
pubmed: 31022500
Eur J Pharm Biopharm. 2021 Aug;165:345-360
pubmed: 34052428
Small. 2009 Jun;5(11):1334-42
pubmed: 19242944
Int J Pharm. 2010 Sep 15;397(1-2):218-24
pubmed: 20637852
Mater Sci Eng C Mater Biol Appl. 2020 Oct;115:111124
pubmed: 32600723
J Pharm Sci. 2020 Nov;109(11):3235-3247
pubmed: 32702373
Molecules. 2019 Dec 27;25(1):
pubmed: 31892180
Adv Drug Deliv Rev. 2019 Jan 1;138:302-325
pubmed: 30639256
Materials (Basel). 2019 Feb 12;12(3):
pubmed: 30759725
ACS Nano. 2015 Oct 27;9(10):9700-7
pubmed: 26394039
Int J Pharm. 2019 Mar 10;558:261-267
pubmed: 30641175
J Adv Pharm Technol Res. 2011 Apr;2(2):81-7
pubmed: 22171298
Int J Pharm. 2021 Mar 1;596:120215
pubmed: 33486021
Mol Pharm. 2016 Jan 4;13(1):295-305
pubmed: 26635214
Pharmaceutics. 2018 Dec 06;10(4):
pubmed: 30563197
Langmuir. 2004 Oct 26;20(22):9852-5
pubmed: 15491224
Int J Pharm. 2022 Dec 15;629:122389
pubmed: 36375684
Eur J Pharm Sci. 2018 May 30;117:331-340
pubmed: 29514051
Int J Biol Macromol. 2019 Mar 15;125:922-930
pubmed: 30553857
Int J Pharm. 2015 Apr 30;484(1-2):57-74
pubmed: 25701683
Cancers (Basel). 2019 Dec 17;11(12):
pubmed: 31861146
ACS Appl Mater Interfaces. 2021 Jan 13;13(1):1883-1894
pubmed: 33389999
J Colloid Interface Sci. 2019 Sep 1;551:242-250
pubmed: 31082533
Adv Drug Deliv Rev. 2019 Jan 1;138:68-104
pubmed: 30553951
Drug Discov Today. 2020 Jan;25(1):141-149
pubmed: 31586641
J Pharm Sci. 2018 Mar;107(3):807-813
pubmed: 29107044
Pharmaceutics. 2021 Jul 21;13(8):
pubmed: 34452072
Eur J Pharm Biopharm. 1998 Sep;46(2):145-51
pubmed: 9795036
J Colloid Interface Sci. 2017 Nov 1;505:605-614
pubmed: 28651200
Mol Pharm. 2016 Apr 4;13(4):1393-404
pubmed: 26950163
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1046-55
pubmed: 23916460
J Control Release. 2010 Feb 25;142(1):138-45
pubmed: 19840823
Int J Pharm. 2017 Jan 10;516(1-2):170-177
pubmed: 27845211
Eur J Pharm Biopharm. 2020 Apr;149:238-247
pubmed: 32112895
J Pharm Sci. 2017 Feb;106(2):446-456
pubmed: 27889072
J Control Release. 2016 Aug 10;235:337-351
pubmed: 27297779
Int J Pharm. 2021 Mar 15;597:120348
pubmed: 33545290

Auteurs

Črt Dragar (Č)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Žan Rekar (Ž)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Tanja Potrč (T)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Sebastjan Nemec (S)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Department for Materials Synthesis, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.

Slavko Kralj (S)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Department for Materials Synthesis, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia.
Nanos SCI, Nanos Scientificae d.o.o., SI-1000 Ljubljana, Slovenia.

Petra Kocbek (P)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Classifications MeSH